- Investing Ideas
- /
- German Pharmaceuticals & Biotech High Growth Potential Companies
German Pharmaceuticals & Biotech High Growth Potential Companies
Results
8
Companies with a Future performance score of at least 3, ordered by Future performance score.
8 companies
Cantourage Group
Market Cap: €80.3m
Operates as a medical cannabis company in Europe.
HIGH
€6.44
7D
11.0%
1Y
-10.6%
SynBiotic
Market Cap: €21.9m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€3.21
7D
0%
1Y
-62.2%
Gerresheimer
Market Cap: €2.2b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€64.05
7D
5.0%
1Y
-37.4%
Evotec
Market Cap: €1.2b
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVT
€7.02
7D
-1.3%
1Y
-17.4%
Apontis Pharma
Market Cap: €96.6m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€11.60
7D
2.7%
1Y
41.8%
Formycon
Market Cap: €399.9m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.65
7D
-0.7%
1Y
-46.8%
PharmaSGP Holding
Market Cap: €313.1m
Manufactures and sells over-the-counter drugs and other healthcare products in Germany.
PSG
€27.20
7D
1.5%
1Y
21.4%
Bayer
Market Cap: €24.2b
Operates as a life science company worldwide.
BAYN
€24.67
7D
4.0%
1Y
-8.4%